Heterogeneous Responses and Resistant Mechanisms to Crizotinib in ALK -Positive Advanced Non-Small Cell Lung Cancer
Thoracic Cancer - Australia
doi 10.1111/1759-7714.12791
Full Text
Open PDFAbstract
Available in full text
Date
July 6, 2018
Authors
Publisher
Wiley